Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 116,613 shares at $30.05 ($3.5M) on 2021-08-30, disclosed to the SEC on 2021-08-30.
Open-market sale of $3.5M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.39 | 15,063 | $458K | 12.9% |
| 2 | $30.39 | 15,063 | $458K | 12.9% |
| 3 | $31.13 | 6,091 | $190K | 5.3% |
| 4 | $31.13 | 6,091 | $190K | 5.3% |
| 5 | $30.50 | 23,397 | $714K | 20.1% |
| 6 | $30.50 | 23,397 |
| $714K |
| 20.1% |
| 7 | $31.06 | 1,045 | $32K | 0.9% |
| 8 | $30.05 | 13,233 | $398K | 11.2% |
| 9 | $30.05 | 13,233 | $398K | 11.2% |
| Total | $30.44 avg | 116,613 | $3.5M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |